Data compatibility in the addiction sciences: an examination of measure commonality.

The need for comprehensive analysis to compare and combine data across multiple studies in order to validate and extend results is widely recognized. This paper aims to assess the extent of data compatibility in the substance abuse and addiction (SAA) sciences through an examination of measure commonality, defined as the use of similar measures, across grants funded by the National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA). Data were extracted from applications of funded, active grants involving human-subjects research in four scientific areas (epidemiology, prevention, services, and treatment) and six frequently assessed scientific domains. A total of 548 distinct measures were cited across 141 randomly sampled applications. Commonality, as assessed by density (range of 0-1) of shared measurement, was examined. Results showed that commonality was low and varied by domain/area. Commonality was most prominent for (1) diagnostic interviews (structured and semi-structured) for substance use disorders and psychopathology (density of 0.88), followed by (2) scales to assess dimensions of substance use problems and disorders (0.70), (3) scales to assess dimensions of affect and psychopathology (0.69), (4) measures of substance use quantity and frequency (0.62), (5) measures of personality traits (0.40), and (6) assessments of cognitive/neurologic ability (0.22). The areas of prevention (density of 0.41) and treatment (0.42) had greater commonality than epidemiology (0.36) and services (0.32). To address the lack of measure commonality, NIDA and its scientific partners recommend and provide common measures for SAA researchers within the PhenX Toolkit.

[1]  Robert M. Anderson.  Halstead-Reitan Neuropsychological Battery , 1994 .

[2]  Joseph Pratt,et al.  PhenX—Establishing a consensus process to select common measures for collaborative research , 2013 .

[3]  M. First,et al.  The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. , 1992, Archives of general psychiatry.

[4]  J. Crabbe,et al.  REVIEW: Consilient research approaches in studying gene × environment interactions in alcohol research , 2010, Addiction biology.

[5]  F. Hu,et al.  Measuring alcohol consumption for genomic meta-analyses of alcohol intake: opportunities and challenges. , 2012, The American journal of clinical nutrition.

[6]  Niels G. Waller,et al.  Exploring personality through test construction: Development of the multidimensional personality questionnaire , 2008 .

[7]  Huaqin Pan,et al.  The PhenX Toolkit: Get the Most From Your Measures , 2011, American journal of epidemiology.

[8]  Simon C. Potter,et al.  Genome-wide Association Analysis Identifies 14 New Risk Loci for Schizophrenia , 2013, Nature Genetics.

[9]  Daniel J Bauer,et al.  Integrative data analysis in clinical psychology research. , 2013, Annual review of clinical psychology.

[10]  G. Matthews,et al.  The SAGE handbook of personality theory and assessment. Volume 1, Personality theories and models , 2008 .

[11]  Gregory J. Boyle,et al.  The SAGE handbook of personality theory and assessment: Volume 2 — Personality measurement and testing , 2008 .

[12]  Matthew C Keller,et al.  A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry. , 2011, The American journal of psychiatry.

[13]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[14]  S. Raudenbush,et al.  Tests for linkage of multiple cohorts in an accelerated longitudinal design. , 2000, Psychological methods.

[15]  Daniel N. Allen,et al.  Trail-Making Test , 2010 .

[16]  Eric Boerwinkle,et al.  The gene, environment association studies consortium (GENEVA): maximizing the knowledge obtained from GWAS by collaboration across studies of multiple conditions , 2010, Genetic epidemiology.

[17]  Sarah E. Medland,et al.  A Quantitative-Trait Genome-Wide Association Study of Alcoholism Risk in the Community: Findings and Implications , 2011, Biological Psychiatry.

[18]  Peter Kraft,et al.  Phenotype harmonization and cross‐study collaboration in GWAS consortia: the GENEVA experience , 2011, Genetic epidemiology.

[19]  Hans Hillege,et al.  Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies , 2010, International journal of epidemiology.

[20]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.

[21]  L. Bierut.  Genetic Vulnerability and Susceptibility to Substance Dependence , 2011, Neuron.